Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Entrada Therapeutics Q3 EPS $(0.80) Up From $(9.78) YoY

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.80) per share. This is a 91.82 percent increase over losses of $(9.78) per share from the same period last year.
byBenzinga Newsdesk
November 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.80) per share. This is a 91.82 percent increase over losses of $(9.78) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts